SCHEMBL27224141

SCHEMBL27224141

CCOC(=O)c1[nH]ccc1NCc1ccc(Cl)cc1C1COCCN1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ GAA P10253 3/20 0.36
▸ F2 P00734 3/20 0.36
▸ MAPT P10636 4/20 0.34
▸ LMNA P02545 3/20 0.34
▸ F9 P00740 2/20 0.34
▸ F10 P00742 2/20 0.34
▸ F12 P00748 2/20 0.34
▸ PRSS1 P07477 2/20 0.34
▸ PRSS2 P07478 2/20 0.34
▸ F7 P08709 2/20 0.34
▸ PRSS3 P35030 2/20 0.34
▸ THRB P10828 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ MDM2 Q00987 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ USP2 O75604 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30749295 0.90 ALOX15 (0.39) ALDH1A1HPGDHSD17B10ALOX15GAA
SCHEMBL27224063 0.90 ALOX15 (0.39) ALDH1A1HPGDHSD17B10ALOX15GAA
SCHEMBL27223421 0.88 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10ALOX15GAA
SCHEMBL27224205 0.88 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10ALOX15GAA
SCHEMBL27223533 0.87 F2 (0.41) ALDH1A1HPGDHSD17B10ALOX15F2
SCHEMBL30601281 0.81 ALOX15 (0.38) ALDH1A1HPGDALOX15F2LMNA
SCHEMBL30601308 0.81 ALOX15 (0.38) ALDH1A1HPGDALOX15F2LMNA
SCHEMBL31556733 0.78 MEN1 (0.40) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL30749240 0.78 MEN1 (0.40) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL30028767 0.78 ALDH1A1 (0.47) ALDH1A1HSD17B10ALOX15GAAF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE MPO, XDH, EPX ALDH1A1 502/4885HPGD 572/4885HSD17B10 1217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback